Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.
Clinical trial NCT04065841 · TERMINATED
Trial details
- NCT number
- NCT04065841
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2022-10-27
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.